LENZ Therapeutics, Inc.
LENZ- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001815776
No open-market purchases or sales by LENZ Therapeutics, Inc. insiders were filed in the last 90 days; 145 institutions reported holding it in 13F filings for Q2 2026, worth $197.3M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in LENZ Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 55
- −8 vs. Q4 2023
- Shares held
- 16.2M
- +11.8M (+265.7%) vs. Q4 2023Converted for a 1-for-7 split
- Total value
- $362.0M
- +$280.5M (+344.2%) vs. Q4 2023
- New holders
- 12
- 14 more added
- Sold out
- 20
- 18 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LENZ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 145 | $197.3M |
| Q1 2026 | 146 | $303.3M |
| Q4 2025 | 161 | $561.6M |
| Q3 2025 | 166 | $1.36B |
| Q2 2025 | 114 | $725.1M |
| Q1 2025 | 105 | $541.8M |
| Q4 2024 | 95 | $573.2M |
| Q3 2024 | 78 | $444.8M |
| Q2 2024 | 65 | $327.0M |
| Q1 2024 | 55 | $362.0M |
| Q4 2023 | 63 | $81.5M |
| Q3 2023 | 67 | $75.8M |
| Q2 2023 | 66 | $81.2M |
| Q1 2023 | 62 | $72.9M |
| Q4 2022 | 66 | $95.6M |
| Q3 2022 | 63 | $93.9M |
| Q2 2022 | 63 | $83.0M |
| Q1 2022 | 63 | $185.7M |
| Q4 2021 | 58 | $431.7M |
| Q3 2021 | 60 | $587.4M |
| Q2 2021 | 51 | $981.4M |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding LENZ Therapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Advisor Group Holdings, Inc. | 2 | $45 | 0.00% | −189−99.0% | ReducedConverted for a 1-for-7 split |
| Federation des caisses Desjardins du Quebec | 28 | $625 | 0.00% | −1−2.0% | ReducedConverted for a 1-for-7 split |
| Royal Bank of Canada | 93 | $2.00K | 0.00% | −1,003−91.5% | ReducedConverted for a 1-for-7 split |
| Amalgamated Bank | 135 | $3.00K | 0.00% | −214−61.3% | ReducedConverted for a 1-for-7 split |
| Lazard Asset Management LLC | 288 | $6.00K | 0.00% | −122−29.8% | ReducedConverted for a 1-for-7 split |
| Ameritas Investment Partners, Inc. | 331 | $7.38K | 0.00% | 00.0% | UnchangedConverted for a 1-for-7 split |
| Legal & General Group Plc | 382 | $8.53K | 0.00% | 00.0% | UnchangedConverted for a 1-for-7 split |
| Tower Research Capital LLC (TRC) | 451 | $10.1K | 0.00% | −195−30.2% | ReducedConverted for a 1-for-7 split |
| California State Teachers Retirement System | 454 | $10.1K | 0.00% | −205−31.1% | ReducedConverted for a 1-for-7 split |
| Group One Trading, L.P. | 571 | $12.8K | 0.00% | 00.0% | UnchangedConverted for a 1-for-7 split |
| Nisa Investment Advisors, LLC | 644 | $14.4K | 0.00% | 00.0% | UnchangedConverted for a 1-for-7 split |
| Citigroup Inc | 750 | $16.7K | 0.00% | +170+29.4% | AddedConverted for a 1-for-7 split |
| Qube Research & Technologies Ltd | 982 | $21.9K | 0.00% | +982 | New |
| Wells Fargo & Company | 1,359 | $30.3K | 0.00% | +54+4.2% | AddedConverted for a 1-for-7 split |
| FMR LLC | 1,373 | $30.7K | 0.00% | +1,223+815.3% | AddedConverted for a 1-for-7 split |
| JPMorgan Chase & Co | 1,682 | $37.6K | 0.00% | −913−35.2% | ReducedConverted for a 1-for-7 split |
| American International Group, Inc. | 1,973 | $44.1K | 0.00% | −17−0.8% | ReducedConverted for a 1-for-7 split |
| New York State Common Retirement Fund | 3,490 | $77.9K | 0.00% | −1,729−33.1% | ReducedConverted for a 1-for-7 split |
| Bank of America Corp | 3,927 | $87.7K | 0.00% | −5,038−56.2% | ReducedConverted for a 1-for-7 split |
| UBS Group AG | 4,271 | $95.4K | 0.00% | −116−2.7% | ReducedConverted for a 1-for-7 split |
| Rhumbline Advisers | 4,598 | $102.7K | 0.00% | +141+3.2% | AddedConverted for a 1-for-7 split |
| Marquette Asset Management, LLC | 5,865 | $131.0K | 0.02% | 00.0% | UnchangedConverted for a 1-for-7 split |
| Barclays PLC | 6,563 | $146.6K | 0.00% | −5,216−44.3% | ReducedConverted for a 1-for-7 split |
| Cornercap Investment Counsel Inc | 9,350 | $208.8K | 0.03% | 00.0% | UnchangedConverted for a 1-for-7 split |
| Bank of New York Mellon Corp | 11,181 | $249.7K | 0.00% | +316+2.9% | AddedConverted for a 1-for-7 split |
| Charles Schwab Investment Management Inc | 11,683 | $260.9K | 0.00% | 00.0% | UnchangedConverted for a 1-for-7 split |
| BNP Paribas Arbitrage, SA | 16,221 | $362.2K | 0.00% | +16,221 | New |
| Bridgeway Capital Management, LLC | 21,920 | $489.5K | 0.01% | −2,759−11.2% | ReducedConverted for a 1-for-7 split |
| Boothbay Fund Management, LLC | 22,601 | $504.7K | 0.01% | +22,601 | New |
| Dimensional Fund Advisors LP | 23,537 | $525.6K | 0.00% | +7,038+42.7% | AddedConverted for a 1-for-7 split |
| Morgan Stanley | 27,211 | $607.6K | 0.00% | −2,043−7.0% | ReducedConverted for a 1-for-7 split |
| Acuitas Investments, LLC | 31,488 | $703.1K | 0.35% | +3,691+13.3% | AddedConverted for a 1-for-7 split |
| Jacobs Levy Equity Management, Inc | 37,176 | $830.1K | 0.00% | +10,598+39.9% | AddedConverted for a 1-for-7 split |
| Northern Trust Corp | 40,639 | $907.5K | 0.00% | +754+1.9% | AddedConverted for a 1-for-7 split |
| Vivaldi Capital Management, LLC | 58,752 | $924.2K | 0.27% | +58,752 | New |
| Renaissance Technologies LLC | 46,866 | $1.05M | 0.00% | −36,156−43.6% | ReducedConverted for a 1-for-7 split |
| BML Capital Management, LLC | 63,916 | $1.43M | 0.96% | 00.0% | UnchangedConverted for a 1-for-7 split |
| Prosight Management, LP | 65,000 | $1.45M | 0.40% | −128,134−66.3% | ReducedConverted for a 1-for-7 split |
| State Street Corp | 65,144 | $1.45M | 0.00% | +3,077+5.0% | AddedConverted for a 1-for-7 split |
| Ikarian Capital, LLC | 85,000 | $1.90M | 0.52% | +85,000 | New |
| Geode Capital Management, LLC | 88,218 | $1.97M | 0.00% | +8,910+11.2% | AddedConverted for a 1-for-7 split |
| Board of Trustees of The Leland Stanford Junior University | 100,438 | $2.24M | 0.20% | 00.0% | UnchangedConverted for a 1-for-7 split |
| Jennison Associates LLC | 134,740 | $3.01M | 0.00% | +134,740 | New |
| Alyeska Investment Group, L.P. | 199,602 | $4.43M | 0.03% | +199,602 | New |
| Vanguard Group Inc | 206,952 | $4.62M | 0.00% | +3,241+1.6% | AddedConverted for a 1-for-7 split |
| BlackRock Inc. | 241,016 | $5.38M | 0.00% | −10,415−4.1% | ReducedConverted for a 1-for-7 split |
| Tang Capital Management LLC | 547,616 | $12.2M | 1.27% | +191,647+53.8% | AddedConverted for a 1-for-7 split |
| RTW Investments, LP | 863,389 | $19.3M | 0.28% | +863,389 | New |
| Point72 Asset Management, L.P. | 864,942 | $19.3M | 0.06% | +864,942 | New |
| 72 Investment Holdings, LLC | 1,017,751 | $22.7M | 33.88% | +1,017,751 | New |
| Sectoral Asset Management Inc | 1,068,675 | $23.9M | 9.38% | +1,005,557+1,593.1% | AddedConverted for a 1-for-7 split |
| Samsara BioCapital, LLC | 1,208,473 | $27.0M | 4.17% | 00.0% | UnchangedConverted for a 1-for-7 split |
| EcoR1 Capital, LLC | 1,219,774 | $27.2M | 0.69% | 00.0% | UnchangedConverted for a 1-for-7 split |
| Falcon Edge Capital, LP | 3,612,211 | $80.7M | 24.51% | +3,612,211 | New |
| Ra Capital Management, L.P. | 4,178,823 | $93.3M | 1.19% | +4,178,823 | New |
| Nordwand Advisors, LLC | 0 | $0 | 0.00% | −143−100.0% | Sold outConverted for a 1-for-7 split |
| Nantahala Capital Management, LLC | 0 | $0 | 0.00% | −117,282−100.0% | Sold outConverted for a 1-for-7 split |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −83,818−100.0% | Sold outConverted for a 1-for-7 split |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −19,329−100.0% | Sold outConverted for a 1-for-7 split |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −18,724−100.0% | Sold outConverted for a 1-for-7 split |
| Millennium Management LLC | 0 | $0 | 0.00% | −12,938−100.0% | Sold outConverted for a 1-for-7 split |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −10,449−100.0% | Sold outConverted for a 1-for-7 split |
| Nuveen Asset Management, LLC | 0 | $0 | 0.00% | −5,677−100.0% | Sold outConverted for a 1-for-7 split |
| BBR Partners, LLC | 0 | $0 | 0.00% | −5,246−100.0% | Sold outConverted for a 1-for-7 split |
| Virtu Financial LLC | 0 | $0 | 0.00% | −4,985−100.0% | Sold outConverted for a 1-for-7 split |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −4,599−100.0% | Sold outConverted for a 1-for-7 split |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −4,083−100.0% | Sold outConverted for a 1-for-7 split |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −4,077−100.0% | Sold outConverted for a 1-for-7 split |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −3,124−100.0% | Sold outConverted for a 1-for-7 split |
| XTX Topco Ltd | 0 | $0 | 0.00% | −2,782−100.0% | Sold outConverted for a 1-for-7 split |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −2,190−100.0% | Sold outConverted for a 1-for-7 split |
| Invesco Ltd. | 0 | $0 | 0.00% | −1,917−100.0% | Sold outConverted for a 1-for-7 split |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −1,767−100.0% | Sold outConverted for a 1-for-7 split |
| Maven Securities LTD | 0 | $0 | 0.00% | −1,429−100.0% | Sold outConverted for a 1-for-7 split |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −10−100.0% | Sold outConverted for a 1-for-7 split |